Markets

Praxair Inc. (PX) Beats Q3 Earnings and Revenues

Praxair Inc.PX engages in the production and distribution of industrial gases, primarily in North America, South America, Europe and Asia. Increased applications of industrial gases in industries like healthcare, petroleum refining, computer-chip manufacturing, beverage carbonation, fiber-optics, steel making, aerospace, chemicals and water treatment is a boon for the company. This Danbury, CT-based company has a $41.1 billion market capitalization.

However, the company face headwinds from unfavorable foreign currency movements, geopolitical issues and a competitive business environment.

Praxair delivered better-than-expected results in three of last four trailing quarters and in-line results in one, with a positive average earnings surprise of 1.46%.

Praxair, Inc. Price, Consensus and EPS Surprise

Praxair, Inc. Price, Consensus and EPS Surprise | Praxair, Inc. Quote

Currently, PX has a Zacks Rank #5 (Sell), but that could definitely change after the release of its upcoming earnings report. You can see the complete list of today's Zacks #1 (Strong Buy) Rank stocks here . We have highlighted some of the key stats from this just-revealed announcement below:

Earnings: Praxair's earnings came in at $1.50 per share in third-quarter 2017. The bottom line result came in above the Zacks Consensus Estimate of $1.44.

Revenue: Revenues surpassed. Praxair generated revenues of $2,922 million. The top-line result came in above the Zacks Consensus Estimate of $2.87 billion.

Key Stats to Note: For 2017, Praxair increased its earnings guidance by 12 cents at mid point to $5.78-$5.83 per share range. Earnings in the fourth quarter are predicted to be within $1.45-$1.50 range.

Stock Price: Praxair shares were up 0.47% ahead of the report.

Check back our full write up on this PX earnings report later!

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Praxair, Inc. (PX): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More